US FDA approves Sanofi's wearable injector form of blood cancer drug

By Sneha S K and Bhanvi Satija July 10 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved a ...
Fierce Pharma

Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector

Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential ...
The American Journal of Managed Care

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

Approval covers all current IV isatuximab indications and introduces the first oncology product labeled for both OBI and manual SC administration. IRAKLIA (NCT05405166) established noninferiority of ...
Cancer Therapy Advisor

Subcutaneous Sarclisa Escena Receives FDA Nod for Multiple Myeloma

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector

Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena ...
Phys.org

Nanotube injector transfers cytoplasmic contents and organelles between living cells safely

Cells are not isolated units; they continuously exchange proteins, genetic material, and even entire organelles with their neighbors. Intercellular transfer influences how tissues develop, respond to ...
News Medical

When Should an Adrenaline Auto-Injector be Used?

An adrenaline auto-injector is an emergency treatment for anaphylaxis; serious and potentially fatal allergic reaction to insect stings, medicines, or food, among others. Anaphylaxis is an ...